LMWH remains useful when oral anticoagulants are difficult to use safely in venous thromboembolism patients
Low-molecular-weight heparin remains useful when oral anticoagulants are difficult to use safely
This narrative review examines low-molecular-weight heparin dosing, anti-factor Xa monitoring, treatment interruption, and switching strateg…
A review suggests low-molecular-weight heparin stays useful when oral anticoagulants are difficult to use safely for patients with venous th…
Narrative review suggests precision interventions for preeclampsia phenotypes
At-a-Glance
This narrative review examines prevention strategies for preeclampsia in pregnant women. The authors note that standard low-dose aspirin eff…
Preeclampsia prevention is moving beyond aspirin for everyone, with new research showing that matching treatments to a woman's specific risk…
Subprophylactic anti-Xa levels linked to higher venous thromboembolism risk in critically ill adults receiving low-molecular-weight heparin
Low blood clot prevention drug levels linked to higher risk in sick adults
A systematic review and meta-analysis of 7,124 critically ill adults reveals that 47% failed to achieve target anti-Xa levels. Subprophylact…
A large review found that nearly half of critically ill adults did not reach safe drug levels. Those with lower levels faced a much higher c…
Concurrent anti-VEGF and anticoagulant use in cancer patients with VTE shows rare bleeding events
Can You Take Blood Thinners With Cancer Drugs Safely?
This retrospective analysis at Hunan Cancer Hospital assessed 208 patients receiving concurrent anti-VEGF agents and anticoagulants for VTE.
New research suggests it is generally safe to use blood thinners with certain cancer treatments.
Network meta-analysis compares prophylactic anticoagulants for central venous catheter-related thrombosis in cancer patients
Cancer Patients May Avoid Clots With Safer Blood Thinner
This network meta-analysis synthesizes data from 19 clinical studies regarding prophylactic anticoagulation in cancer patients with central …
A new analysis shows one specific blood thinner may protect cancer patients from dangerous clots with fewer side effects.
Network meta-analysis of LMWH and aspirin for high-risk singleton pregnancies with fetal growth restriction
New Treatment Cuts Risk of Dangerous Pregnancy Complication
This network meta-analysis evaluated low-molecular-weight heparin (LMWH) and low-dose aspirin (LDA) in singleton pregnancies at high risk of…
Low-dose blood thinners combined with aspirin significantly reduce the risk of dangerous fetal growth restriction in high-risk pregnancies.
Protocol outlines individualized anticoagulation monitoring in critically ill adults using unfractionated or low-molecular-weight heparin
ICU Blood Clot Prevention Has a Monitoring Problem — This Study Aims to Fix It
This study protocol describes a prospective observational cohort design evaluating individualized anticoagulation monitoring in critically i…
A new prospective study is testing whether a real-time clotting test called viscoelastic testing can give ICU doctors a more complete pictur…
Early LMWH prophylaxis in surgical patients with severe hypertensive intracerebral hemorrhage
The Blood Thinner Timing Puzzle After a Brain Bleed
This retrospective cohort study evaluated early low-molecular-weight heparin calcium prophylaxis for venous thromboembolism in 123 surgical …
After brain bleed surgery, doctors face a tough choice — start blood thinners early to prevent leg clots, or wait and risk a dangerous clot …
Systematic review links neutrophil extracellular trap dysregulation to pregnancy complications
Web of White Blood Cells Linked to Pregnancy Risks
A systematic review of emerging evidence indicates that dysregulation of neutrophil extracellular trap (NET) formation and clearance is stro…
A sticky web of white blood cells meant to fight germs can instead trigger serious pregnancy risks like preeclampsia and preterm birth when …